GLP-1 analogues, GH axis modulators, lipid metabolism compounds. Triple-verified. COA public. For research use only.
The most-researched metabolic peptides in preclinical literature. All 3-lab verified. For research use only.
Long-acting GLP-1 receptor agonist. Studied in Phase III trials for glycemic signaling, appetite regulation, and body composition research. For research use only.
C-terminal fragment of growth hormone. Studied for lipid metabolism signaling and adipogenesis regulation. No impact on IGF-1 in preclinical models. For research only.
Dual GIP and GLP-1 receptor agonist. Studied for synergistic effects on glucose-dependent insulin secretion and body composition signaling. For research use only.
Selective NNMT inhibitor studied for adipocyte metabolism, energy expenditure, and lipid oxidation signaling. Available in capsule form. For research only.
Triple agonist — GLP-1, GIP, and glucagon receptors. Early-phase research on metabolic signaling, adipogenesis, and energy homeostasis. For research use only.
Triple monoamine reuptake inhibitor. Studied for energy balance, appetite signaling, and metabolic pathway research. Available in tablet form. For research only.
Get notified when new metabolic compounds are verified and added.